Endometrial cancer (EC) is the fourth most common cancer in United States women, and alarmingly, the frequency and mortality from EC continues to rise, in part…

Endometrial CancerMetastasisEndometrioid Endometrial Cancer+5 more

~Estimated

~$10 – $6,250

UNC Lineberger Comprehensive Cancer CenterNCT05542407

Phase 2

A Phase 2 Multi-center Open-label Trial of Nab-Sirolimus in Combination With Letrozole in Advanced or Recurrent Endometrioid Endometrial Cancer

A Phase 2 Multi-center Open-label Trial of nab-Sirolimus in Combination with Letrozole in Advanced or Recurrent Endometrioid Endometrial Cancer

Endometrial CancerEndometrioid TumorCancer+3 more

~Estimated

~$10 – $8,750

Aadi Bioscience, Inc.NCT05997017